Or just therapies that also affect glucose control and insulin needs and have some side effects typical or more frequent in type 1 diabetes? Benefits of adjunctive therapies The benefits of GLP-1s, SGLT-2s, and metformin for type 1 diabetes are widely documented, both in clinical research and in anecdotes from people with diabetes
Safety Considerations and Side Effects Like all medications, GLP-1 drugs have potential side effects: Common side effects include: Nausea, vomiting, diarrhea (usually improving over time) Constipation Stomach pain or indigestion Injection site reactions (mild redness or itching) Less common but more serious concerns include: Pancreatitis (inflammation of the pancreas) Kidney problems Gastroparesis (stomach paralysis) in rare cases Joint and bone issues like arthritis and tendinitis Researchers found no established link between GLP-1 medications and pancreatitis, pancreatic cancer, or thyroid cancer in large studies with years of follow-up
Jason Finkelstein (MD), will oversee your treatment plan and ensure its customized to your specific health profile and weight loss goals
Another contender to Wegovy is Eli Lillys Zepbound, another GLP-1 receptor agonist for obesity that was welcomed by the FDA in November
This is the bacteremia risk discussed earlier